• All
  • Primary Antibodies
  • Conjugated Antibodies for IF
  • Conjugated Antibodies for FC
  • Secondary Antibodies
  • Antibody Labeling KitsNew
  • ELISA Kits
  • IHC Kits
  • Magnetic Cell Separation Kits
  • Cytokines & Growth Factors
  • Neutralizing/activating Antibodies
  • Nanobody-based Reagents
  • Accessory Products and Kits
  • Fusion Proteins
×
×
Host
0
Species Reactivity
0
Species Reactivity
0
Conjugate
0
Conjugate
0
Compatible Species
0
Conjugate
0

PKD1L2 Polyklonaler Antikörper

PKD1L2 Polyklonal Antikörper für WB, Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human

Anwendung

WB, Indirect ELISA

Konjugation

Unkonjugiert

Kat-Nr. : 16333-1-PBS

Synonyme

Filter:
  • Western Blot (WB) analysis of various lysates using PKD1L2 Polyclonal antibody (16333-1-AP)

    WB analysis using 16333-1-AP (same clone as 16333-1-PBS)

    Various lysates were subjected to SDS PAGE followed by western blot with 16333-1-AP (PKD1L2 antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours. This data was developed using the same antibody clone with 16333-1-PBS in a different storage buffer formulation.

Geprüfte Anwendungen

Produktinformation

16333-1-PBS bindet in WB, Indirect ELISA PKD1L2 und zeigt Reaktivität mit human

Getestete Reaktivität human
Wirt / Isotyp Kaninchen / IgG
Klonalität Polyklonal
Typ Antikörper
Immunogen PKD1L2 fusion protein Ag9455
Vollständiger Name polycystic kidney disease 1-like 2
Berechnetes Molekulargewicht306aa,33 kDa; 2459aa,273 kDa
Beobachtetes Molekulargewicht270 kDa
GenBank-ZugangsnummerBC014157
Gene symbol PKD1L2
Gene ID (NCBI) 114780
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Antigen-Affinitätsreinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

PKD1L2 is a member of the polycystin protein family. PKD1L2 may function as a G-protein-coupled component or regulator of cation channel pores. The long isoform of this protein contains 11 transmembrane domains, a latrophilin/CL-1-like GPCR proteolytic site (GPS) domain, and a polycystin-1, lipoxygenase, alpha-toxin (PLAT) domain.